BiologicsCOVID-19Regulatory

Why Antibiotic Resistance Is More Worrisome Than Ever

May 14, 2020 / SUSAN BRINK

A health crisis is rapidly unfolding worldwide. It causes suffering and death, costs billions and threatens to overwhelm health-care systems, patients and their families.

No, it’s not the coronavirus pandemic. It’s that other disastrous health crisis: drug resistance. Bacteria and other microbes that cleverly change and evolve are outsmarting the antimicrobials once hailed as miraculous cures. Worldwide, 700,000 people die each year due to drug-resistant diseases, according to the World Health Organization.

Until a few months ago, drug-resistant disease was one of the world’s top health concerns. Now it takes a back seat to the coronavirus pandemic. Muhammad Hamid Zaman is a Howard Hughes Medical Institute Professor at Boston University. His book, Biography of Resistance: The Epic Battle Between People and Pathogens, was released by Harper Wave on April 21.

We talked to Zaman about these two epic health crises.

READ THE REST HERE

Print Friendly, PDF & Email
Tags

Mike Adams

Mike Adams is a medical device sales leader with extensive clinical experience in spine and biologics and a nationwide distribution network built over the last 10+ years in the industry. He has held various leadership positions in healthcare and device including Distributor Partner, Hospital COO and Spine VP of Sales. He currently leads the commercialization strategy for OrthoSpine Partners and is a Distributor Principal at Novel Medical. Because of his unique career path, Mike has the ability to see the healthcare business from multiple perspectives making him passionate about building strategic partnerships that help reduce overall costs, drive innovation, and cultivate growth for new markets.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button
Close